Startup

Jul
13

Diolog launches world’s first two-way communications platform to bring archaic investor relations model into the future

Diolog, the Australian technology company and investor communications software, has today launched in Australia.

DETAIL
Jul
11

Unveiling the true cost: Exploring the factors that influence the development expenses of building a successful app

Building an app is a complex undertaking that requires careful consideration of a number of factors, including budgeting. The ultimate goal of any app development project is to deliver value to both the users and the business. 

DETAIL
Jul
05

Brisbane-based electric vehicle charging start up EVOS closes $5m funding round

EVOS, a start-up specialising in fleet energy management and AC charging for electric vehicles (EVs), today announced that it has completed a funding round, securing $5m from existing investors.

DETAIL
Jul
04

MedTech startup Kali Healthcare raises $1 million in pre-seed round

Kali Healthcare, has closed a $1 million pre-seed round for a new wearable device and digital health platform that will provide better access to safe and reliable monitoring during pregnancy.

DETAIL
Jun
28

Nick Bell’s Superist Group launches AI powered ‘Budget SEO’ agency to help small businesses get online

Superist Group has launched Budget SEO, a new agency focused on offering business owners a unique low cost, high impact SEO agency service.

DETAIL
Jun
20

Midnight Health secures up to $24m in series B capital raise

Midnight Health has announced today that they have secured up to $24 million in funding from nib holdings limited (nib) (ASX: NHF).

DETAIL
Jun
20

Canopus Networks announces partnership with ad-tech pioneer Infomo Global

Canopus Networks announced a partnership with Infomo Global, to jointly provide telcos all over the world an end-to-end, in-house advertising platform that is targeted and secure, with complete consumer privacy.

DETAIL
Jun
05

ImmVirX raising $25m led by renowned healthcare VC OneVentures

ImmVirX Pty Limited has announced that it is raising up to A$25 million via Series B preference shares (“Offer”), funding the Company’s clinical development through to 2026.

DETAIL